Coronary

Discussion in 'Abbott Vascular' started by anonymous, Apr 10, 2019 at 2:29 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    I was contacted about a Coronary account manager position. Looking for some insight on this space. Was told 170k at plan with most earning above that. Currently in the OR but looking to get into the vascular side. Is this a healthy opportunity?
     

  2. anonymous

    anonymous Guest

    Ha. Who did you speak with?
    Recruiter or an Abbott RM or AD?
    Also what territory or area?
     
  3. anonymous

    anonymous Guest

    Recruiter. Midwest
     
  4. anonymous

    anonymous Guest

    Absorb is a blockbuster. You will make millions $$$.
     
  5. anonymous

    anonymous Guest

    Be careful, ASPS are falling through the floor and Abbotts stent is inferior to BSX and Medtronic in terms of visibility. its all contract driven as well
     
  6. anonymous

    anonymous Guest

    With the addition of St. Jude does Abbott have a large piece of the GPO pie? What’s the contract side look like with Medtronic and Boston?
     
  7. anonymous

    anonymous Guest

    St Jude did nothing for ABT. They got rid of the only good thing from STJ and that is the Angio-seal. Terumo got the big end of that small stick. Mdt has a name and a valve. Bsc has watchman, valve. More to bargain with. Abt is being whooped all over the country.
     
  8. anonymous

    anonymous Guest

    Just had an in-person interview for a Coronary role and most of the above seems true based on what the manager said. BSX has most of the contracts in the area and seems to be the leader in the DES space. Seems like the focus would be their OTC product over stents. Was told comp would start around 180 but if territory grows obviously the comp would. Also know two reps out on the west coast in the mid 200's but contracts are more in their favor.
     
  9. anonymous

    anonymous Guest

    Yes, that is accurate. Current Coronary rep. BSX and MDT have the contracts in most areas due to the reasons above. Until we start contracting with Mitraclip and when the valve comes out it will be hard to win the big ones. However, OCT is a main focus but most of your pay is with DES. There are different tiers for comp which mid-size territories start at 170-180 and large territories start at 210 and up. Overall great company and paid well during the lockdowns. Great place to start and move into TAVR eventually.
     
  10. anonymous

    anonymous Guest

    How about the sexual harassment? Same across the board at Abbott? Also, isn’t TAVR a me too product just like coronary?
     
  11. anonymous

    anonymous Guest

    yes yes and yes!
     
  12. anonymous

    anonymous Guest

    Big problems here. TAVR is not a strong product.